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Background: Machine learning (ML) is increasingly being used in many areas of health care. Its use in
infection management is catching up as identified in a recent review in this journal. We present here a
complementary review to this work.
Objectives: To support clinicians and researchers in navigating through the methodological aspects of ML
approaches in the field of infection management.
Sources: A Medline search was performed with the keywords artificial intelligence, machine learning,
infection*, and infectious disease* for the years 2014e2019. Studies using routinely available electronic
hospital record data from an inpatient setting with a focus on bacterial and fungal infections were
included.
Content: Fifty-two studies were included and divided into six groups based on their focus. These studies
covered detection/prediction of sepsis (n ¼ 19), hospital-acquired infections (n ¼ 11), surgical site in-
fections and other postoperative infections (n ¼ 11), microbiological test results (n ¼ 4), infections in
general (n ¼ 2), musculoskeletal infections (n ¼ 2), and other topics (urinary tract infections, deep fungal
infections, antimicrobial prescriptions; n ¼ 1 each). In total, 35 different ML techniques were used. Lo-
gistic regression was applied in 18 studies followed by random forest, support vector machines, and
artificial neural networks in 18, 12, and seven studies, respectively. Overall, the studies were very het-
erogeneous in their approach and their reporting. Detailed information on data handling and software
code was often missing. Validation on new datasets and/or in other institutions was rarely done. Clinical
studies on the impact of ML in infection management were lacking.
Implications: Promising approaches for ML use in infectious diseases were identified. But building trust
in these new technologies will require improved reporting. Explainability and interpretability of the
models used were rarely addressed and should be further explored. Independent model validation and
clinical studies evaluating the added value of ML approaches are needed. C.F. Luz, Clin Microbiol Infect
2020;▪:1
© 2020 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Artificial intelligence (AI), defined as computer algorithms
exhibiting cognitive-like features such as learning capabilities, isMedical Microbiology and
ingen, Hanzeplein 1, 9713 GZ
Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).
ne learning in infectionmana
crobiology and Infection, httpalready impacting our lives in various areas. In the medical field AI-
supported image analysis has already gained an important role in
radiology, dermatology, and pathology [1]. In another data-intense
discipline, genomics, AI helps to predict phenotypes from geno-
types [2].
Computer algorithms for AI rely largely on machine learning
(ML) techniques in a broad sense, including natural language pro-
cessing and computer vision [3]. A recent review on ML in
healthcare epidemiology defined ML as the study of tools and
methods for identifying patterns in data [4]. ML techniquesof Clinical Microbiology and Infectious Diseases. This is an open access article under
gement using routine electronic health records: tools, techniques, and
s://doi.org/10.1016/j.cmi.2020.02.003
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cision trees, or deep learning) that can be categorized into super-
vised, unsupervised, and reinforcement learning techniques (Fig.1).
While unsupervised learning provides methods for clustering data,
supervised learning is focused on classification. A detailed intro-
duction to the background of ML in health care has recently been
published [5].
Patient medical data are increasingly being stored as electronic
health records (EHRs) at healthcare institutions worldwide. For
example, hospitals in high-income countries use EHRs containing
basic functionalities such as patient demographics, physician notes,
nursing assessments, patient problem lists, patientmedication lists,
discharge summaries, radiology reports, diagnostic test results, and
order entries for medications [6]. However, EHRs can be inconsis-
tent and noisy, may contain many missing values, and frequently
include unstructured text fields. Nevertheless, the very fact that
these data are electronically available in large volumes provides the
potential for applying ML, including in the field of infection man-
agement. For example, life-threatening conditions like sepsis
require immediate diagnostic and therapeutic actions at a time
when the causative pathogen is often still unknown [7]. Early
identification of septic patients through ML-derived prediction
models could improve and facilitate patient care in situations
where ‘time is life’ [8].
A recent review listed current applications of ML for clinical
decision support in infectious diseases and identified different aims
such as support of diagnosis, severity prediction, and choice of
appropriate antimicrobial treatment [9]. This resource provides a
comprehensive overview of objectives and characteristics of ML
systems with a special focus on variable selection for ML ap-
proaches. Our aim is complementary to this work in identifying and
describing different methodological approaches, performanceFig. 1. Machine learning types and concepts of included studies. Supervised learning requir
whereas unsupervised learning can suggest/predict labels. Icons display simplified algorithm
learning concept(s) behind an algorithm/technique. Multiple concepts per algorithm/techn
Please cite this article as: Luz CF et al., Machine learning in infectionmana
reporting of future technologies, Clinical Microbiology and Infection, httmeasures, and future methodological requirements for optimal use
of ML in infection management.
Methods
We queried the MEDLINE database for articles published within
the last 5½ years (2014-01-01 until 2019-08-20) using the terms
machine learning or artificial intelligence and infection* or infectious
disease*. The time span was selected to focus on recent de-
velopments that are in line with current technologies available to
researchers and clinicians. Articles were included and assessed if
they used routinely available EHR data in a retrospective manner
with a focus on bacterial and fungal infection management.
Exclusion criteria were pure laboratory or image data analyses (e.g.
whole-genome sequencing data, CT scans), free text-based analyses
(e.g. natural language processing), reviews and commentaries, or
other non-routine data collection (e.g. phone follow-up question-
naire data as part of a clinical trial). This search strategy and the
inclusion criteria are similar to those of a recent, complementary
review [9]. Yet, while this review included search terms related to
decision-making, we took a broader approach without such terms
to also include studies with more experimental study designs that
might not yet focus on direct clinical application. This is important
to capture and assess different methodological approaches in this
early phase of ML applications in infection management.
Articles were assessed on their research focus (e.g. sepsis,
hospital-acquired infections) and mapped to research areas. Defi-
nitions of the predicted/labelled outcome (e.g. sepsis defined by
diagnostic code) were evaluated. Furthermore, information on the
used ML model techniques and model performancedarea under
the receiver operating characteristic curve (AUROC), sensitivity,
specificitydwere extracted. Additionally, study size, number ofes labelled outcomes (‘ground truth’, e.g. sepsis ¼ TRUE or FALSE) in the training phase
setups/learning concepts. Letters in red behind abbreviations and names indicate the
ique are possible.
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handling, and information on external model validation or trials
were assessed.Results
We identified 52 articles (12 from 2019, 17 from 2018, seven
from 2017, eight from 2016, four from 2015, and four from 2014).
After assessing the research focus of the articles, six research areas
could be determined: sepsis (n ¼ 19), hospital-acquired infections
(HAIs; n ¼ 11), surgical site infections (SSIs) and other post-
operative infections (n ¼ 11), microbiological test results (n ¼ 4),
infections in general (n¼ 2), musculoskeletal infections (n¼ 2), and
other focuses: urinary tract infections (UTIs), deep fungal in-
fections, antimicrobial prescriptions, each n ¼ 1 (Table 1).Data underlying identified machine learning studies
The study size (i.e. number of patients) of all included studies
ranged from 148 to 500,000 with a median of 5471. The median
number of features/variables included was 30 (range: 2e23,968).
Summary characteristics of the identified studies per research area
are described in Table 1.
Data were extracted from local EHR systems in 42 studies (81%).
Eleven studies [10e20] used a publicly available critical care data-
base (MIMIC version II and III) [21].
Pre-processing of data was reported to varying degrees. Missing
data handling was not described in 39% of the studies (n ¼ 20).
When reported, different strategies were applied: e.g. trans-
formation to binary variables indicating missingness [22], carry-
forward of last observation [12,14,20,23e26], including complete
cases only [18,27e30], or applying multiple imputation
[11,17,31e35]. Two studies assessed the effect of missing data on
model performance through a stepwise introduction of missing
variables [36,37]. Class imbalance of the labelled outcome variable
was explicitlymentioned if applicable in 39% (n¼ 18) of the studies.
Of the 41 studies (79%) reporting on the software used for
modelling, 30 (73.2%) used open-source programming languages
such as R or Python. However, only six (11.5%) studies made their
code publicly available [38e43].Machine learning techniques in use
Overall, 35 differentML techniqueswere used in the 52 included
studies. Logistic regression (LR) was used in 18 studies (51.4%) but
usually as a reference to reflect traditional model approaches.
Random forest (RF), support vector machines (SVM), and artificialTable 1
Summary characteristics per research area
Research area n Features/variables (n)
Median Range
Sepsis 19 17 2e3058
Hospital-acquired infections 11 54 19e23,968
SSI and other postoperative infections 11 50 10e9828
Microbiological test results 4 92 50e134
Infection (general) 2 6 6
Musculoskeletal infections 2 73 68e78
Other (antimicrobial prescription) 1 e e
Other (deep fungal infection) 1 19 e
Other (urinary tract infections) 1 211 e
AUROC, area under the receiver operating characteristic curve; LSTM, long short-term m
regression; CART, classification and regression tree; SVM, support vector machines; SGB,
extreme gradient boosting.
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seven (20.0%) studies, respectively.
Forty-eight studies (92%) used supervised learning approaches,
i.e. developing the model by training using input data with the
corresponding output label (Fig. 1). Three studies used an unsu-
pervised clustering approach for clustering sepsis patients
[31,42,44]. Data from sepsis patients were also used to learn
optimal treatment by reinforcement learning [19].
In 43 studies (82.7%) an AUROC was reported, of which 27
(62.8%) achieved an AUROC >0.80, which is considered as an
excellent discrimination performance [45]. Sensitivity and speci-
ficity, however not relevant for all ML tasks, were reported by 32
(61.5%) studies (Fig. 2).
Thirty studies (57.7%) comparedmultipleML techniques. Among
these studies, the best performing techniques per research area
were long short-termmemory networks (LSTM) in the sepsis group
[12,46], ANN in the HAI group [28], L1-regularized logistic regres-
sion (L1LR) in the SSI and other postoperative infections group [26],
SVM in the infections (general) group [37], classification and
regression tree (CART) in themicrobiological test results group [47],
and stochastic gradient boosting (SGB) in the musculoskeletal in-
fections group [35]. However, as outlined below, the definition of
the predicted outcome can be very heterogenous. Thus, compara-
bility of the different approaches per research area is limited and
should be interpreted with great caution.Predicted outcomes per research area
When applying supervised ML techniques, the outcome of
interestdi.e. the event that should be predicteddneeds to be
labelled (e.g. sepsis onset defined by ICD code together with a time
stamp). The predicted outcome in the identified studies are very
diverse and differ greatly even within a given research area
(Table 2).
A detailed list of all studies included in this review can be found
in the Appendix.Discussion
Even within each research area remarkable differences were
found. The following sections highlight the great heterogeneity
between the identified studies, with a focus on challenges in pre-
dicted outcome definitions, outcome and data complexity, report-
ing standards, model performance and validation, and model
interpretability. For a detailed description and assessment of pa-
tient variables used for ML models, readers are referred to the
complementary review of Peiffer-Smadja et al. in this journal [9].Study size (n) Best model Max AUROC
Median Range
5803 242e122,670 LSTM 0.96
11,251 148e 256,732 ANN 0.92
5214 1005e483,686 L1LR 0.96
1234 376e3327 CART 0.77
330,154 160,307e500,000 SVM 0.84
710 367e1053 SGB 0.89
2,442 e TIM e
696 e ANN 0.83
80,387 e XGB 0.90
emory neural network; AN, artificial neural network; L1LR, L1-regularized logistic
stochastic gradient boosting; TIM, temporal induction of classification models; XGB,
gement using routine electronic health records: tools, techniques, and
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Fig. 2. Receiver operating characteristic space of reviewed articles with reference number in brackets; model performance in relation to the research area and study size for studies
reporting performance measures (n ¼ 32). Sensitivity and specificity of the applied models are plotted for the predicted outcome (e.g. sepsis). Due to very heterogeneous studies,
outcomes, and outcome definitions, comparability is limited and should be done with great caution. HAI, hospital-acquired infection; SSI, surgical site infection.
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The identified studies could be grouped into several research
areas. Studies on the identification/prediction of sepsis predomi-
nate, underscoring a special interest in this field. A similar rele-
vance of this group was found in the complementary review [9].
Severely ill sepsis patients are usually admitted to ICUs with
extensive data collection through monitoring and testing that can
be used for ML approaches. Thirteen (68%) of the 19 studies in the
sepsis research area were based on ICU data only, of which nine
(69%) used publicly accessible data [21]. Although similar datawere
used, the predicted outcomes used by the 19 sepsis
studiesebacteraemia, ICD codes, clinical sepsis definitions, clusters
of septic patients, or sepsis-associated mortalitydwere very het-
erogeneous and thus difficult to compare. This heterogeneity was
also observed in the group of SSI and other postoperative in-
fections. National guidelines for these complications were used by
some studies to define the predicted outcome [29,56,64]. None-
theless, different complications differ in their predictability, as seen
in one study using optimal classification trees (OCTs) with perfor-
mances ranging from an AUROC of 0.67 for superficial SSI to 0.93 for
septic shock [56]. The authors hypothesized in their openlyPlease cite this article as: Luz CF et al., Machine learning in infectionmana
reporting of future technologies, Clinical Microbiology and Infection, httavailable response to reviewers that performance values for specific
outcomes, such as superficial SSI, tend to be much lower due to the
collected data being less suitable for predicting less severe or local
complications. Instead the data better reflect patients' general state
and major complications.
This phenomenon is also underscored by a study in the HAI
group predicting central line placement and central-line-associated
bloodstream infections (CLABSIs) [10]. The ML model achieved an
AUROC of only 0.64 when modelling CLABSI but 0.82 for modelling
the placement of a central line. Given the logic above (data being
more predictive for general states and major complications), it
appears reasonable to argue that the placement of a central line is a
proxy for the patient's worsening condition and thus is easier to
model more accurately. It also needs to be kept in mind that
modelling the placement of a line may, in fact, be modelling phy-
sicians' behaviour. This behaviour is likely to be very much
informed by the available data and thus be of better use for
modelling.
While antimicrobial resistance (AMR) is a major concern in
infection management, only three studies addressed this topic
[24,60,61], one of which falls into the area of antimicrobial stew-
ardship [24]. Since AMR constitutes an increasing threat to patientsgement using routine electronic health records: tools, techniques, and
ps://doi.org/10.1016/j.cmi.2020.02.003
Table 2
Predicted outcomes per research area
Research area Definition of the predicted outcome Reference
Sepsis Bacteraemia (positive blood culture result) [32,46,48]
Sepsis based on ICD codes [11e13,15,16,20,23]
Clinical definition of sepsis (e.g. the third international consensus definitions for sepsis and septic shockdSepsis-3) [14,19,25,49]
Clustering septic patients (unsupervised) [42,44]
Sepsis-associated mortality [18,22,31]
HAI Line-associated infections [10,28,39,50]
HAI defined by ICD codes [17]
Clinical definition of HAI (clinical manifestation plus microbiological confirmation) [51]
Clostridium difficile infections [38,41,43,52,53]
SSI and other
postoperative infections
“Any case of opening a wound or use of antibiotics” (original quote from the authors) [33]
“Any superficial, deep, organ space SSI and wound dehiscence” according to national guidelines (NSQIP/NSQIP-P) [29,54]
ICD-10 or NOMESCO Classification of Surgical Procedures (NCSP) codes [26,34,55]
18 individual postoperative complications according to national guidelines (ACS-NSQIP) [56]
SSI according to CDC and clinical diagnosis [27,30,57]
Postoperative infection on the basis of local sets of quality indicators [58]
Microbiological test results Infections with microorganisms with an extended-spectrum b-lactamase (ESBL) in bacteraemic patients [47]
Gram-stain of isolates from a positive blood culture [59]
Colonization with carbapenem-resistant organisms (CREs) [60]
Infections with methicillin-resistant Staphylococcus aureus (MRSA) in bacteraemic patients [61]
Infections (general) “Pre-determined clinical case definition” (original quote from the authors) [36]
“Any type of infection”; positive microbiological culture (original quote from the authors) [37]
Musculoskeletal infections “Failure of non-operative management” (original quote from the authors) [62]
Spinal epidural abscess-associated mortality [35]
Other Identification of inappropriate antimicrobial prescriptions [24]
Deep fungal infections based on “clinical manifestations, laboratory tests and/or identification of fungi”
(original quote from the authors)
[63]
Urinary tract infections (positive urine culture defined by >104 colony forming units/high-powered field) [40]
ICD, International Classification of Diseases; HAI, hospital-acquired infection; SSI, surgical site infection; CDC, Centers for Disease Control and Prevention.
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to further explore the use of ML as a component of innovative so-
lutions. Due to the use of outpatient data, a recent study on the
prediction of AMR in urinary tract infections based on personal
clinical history was not included in this review [67]. However, it
presented an interesting approach using a gradient-tree-boosting
(GTB) algorithm that enabled personalized drug-specific pre-
dictions of AMR in patients with urinary tract infections. Moreover,
this study retrospectively evaluated the rate of mismatched
empirical treatment recommendations by physicians compared to
algorithmic drug recommendations based on the ML predictions.
The latter performed significantly better overall (30% lower mis-
matched treatment rate). In general, studies onML approaches tend
to report model performance measure only. A study design such as
that described above can help to put model development into
clinical perspective and to highlight the added value of the devel-
oped model.Outcome and data complexity
Infectionmanagement is highly complex. The cumulative nature
of information acquisition in clinical reasoning (e.g. turnaround
time of diagnostics from bed to bench and back) creates scenarios
where no specific/definite information might be available on the
causative pathogen. At the same time, increasing AMR demands a
responsible use of anti-infective therapies.
Modelling these medical processes is challenging. Machine
learning techniques like LSTM can analyse complex time series data
and try to follow a similar logic to that clinicians use. LSTM models
constitute a specific set of ML techniques that have been shown to
be successful when predicting non-infection patient outcomes in
EHR [68]. LSTM models might be better suited to identifying/pre-
dicting sepsis and other infection management processes with
their complexities as described above. Predicting positive blood
cultures 12 h in advance in a group of ICU patients receiving blood
culture tests resulted in an AUROC of 0.96 using this modellingPlease cite this article as: Luz CF et al., Machine learning in infectionmana
reporting of future technologies, Clinical Microbiology and Infection, httptechnique [46]. Early sepsis detection based on defining the time of
sepsis onset using ICD codes and timestamps achieved an AUROC of
0.93 [12].
The use of deep learning techniques (a special set of ML tech-
niques) for EHR analysis has been described recently [69]. The
authors provide useful technical background details about the
techniques and assess their use for EHR data extraction, outcome
prediction, or de-identification of EHR data. Although different in
scope, similar aspects to this review could be identified as chal-
lenges: data heterogeneity, benchmarks, and model
interpretability.
In contrast to supervised ML models, unsupervised approaches
for cluster analysis were used by only three studies identified in our
review [31,42]. All three focused on sepsis patients. Given the high
complexity of these patients, unsupervised methods can provide
promising potential to better understand this population. The
studies aimed at identifying treatment patterns, clinical pheno-
types, and mortality-associated patient groups (methods used:
latent Dirichlet allocation [42], partitioning around medoids
methods [44], and composite mixture models [31] respectively)
(Fig. 1). It can be speculated that more studies on unsupervised
methods for heterogeneous patient populations will follow, and it
would be highly interesting to explore the potential of these
methods further.Reporting standards
It was recently pointed out that “methodological, ethical, and
data security standards”, when investigating ML and its application
in healthcare, are greatly needed [5]. Looking at the heterogeneity
of the articles included in our review we fully support this state-
ment. For example, we found only six articles providing openly
available code. This is particularly worrisome not only because of
the debate on reproducibility [70] but also as ML tools are often
being criticized as black boxes. Themaintainers of the public MIMIC
data repository lead the way in providing open source codegement using routine electronic health records: tools, techniques, and
s://doi.org/10.1016/j.cmi.2020.02.003
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reproducibility [21]. There has beenwork on the standardization of
REporting of studies Conducted using Observational Routinely-
collected health Data (RECORD) [71]. The authors state that “A
complete list of codes and algorithms used to classify exposures, out-
comes, confounders, and effect modifiers should be provided.”
Furthermore, reports should include a “[...] discussion of misclassi-
fication bias, unmeasured confounding, missing data, and changing
eligibility over time [...]” [71]. Furthermore, the guideline for trans-
parent reporting of a multivariable prediction model for individual
prognosis or diagnosis (TRIPOD) lists several checkpoints relevant
to ML research [72]. We found only three studies (6%) that
acknowledge following reporting guidelines such as TRIPOD
[22,35,40].
Among the 52 articles in our review, 20 (39%) did not report how
missing data were handled. This greatly hinders comparability,
reproducibility, further use of the reported approaches, and trust in
ML technologies. Routinely available data are not collected focusing
on research. Thus, this can create challenges in accuracy and
completeness [73]. Accounting for this fact through transparent
methodology and reporting is even more important when using
routine data for research and informing decision-makers based on
the derived prediction models. Cleaning and transforming data are
often said to be 80% of the entire work. This should be described in
detail in scientific reports using EHR data.
Model performance and validation
The performance of supervised ML models is most often eval-
uated using measures such as sensitivity, specificity, positive and
negative predictive values, and the AUROC in particular, which was
also found in the majority of the studies in this review. However,
the clinical usefulness of a model identified by a single best AUROC
(of potentially hundreds of models) cannot be assessed by these
standard traditional measures [74]. Furthermore, the clinical pic-
ture (e.g. in sepsis [75]) and the diagnosis of an infection itself is
very heterogeneous and not always binary. Any binary approach
could, thus, lead to overestimation of the effect of a diagnostic tool.
In addition, staff availability, constrained workflows, and cost
define the potential clinical impact of a given model. Additional
analysis would be required and should be incorporated when
evaluating clinical ML models. One good example was a study in
this review that included financial aspects (costs of blood tests) in
the model evaluation [26].
Essential next steps, prior to any application of ML models in
clinical practice, are external model validation and clinical trials.
While all of the identified studies in this review used some rules for
splitting training and test data during model development (e.g. 80%
training and 20% test data), only three studies validated the
developed models on an independent, external dataset [19,23,25].
This hinders statements about generalizability or transferability.
Furthermore, this could also introduce model bias. An ML modelFig. 3. Approach for explaining individual predictions highlighting the variables
Please cite this article as: Luz CF et al., Machine learning in infectionmana
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other subgroups or could even be systematically discriminating
against specific populations (e.g. racial discrimination) [76]. First
studies addressing health disparities using AI exist [77,78]. Studies
such as a randomized controlled trial with a group of patients
treated without the ML model information compared to a group of
patients with this information available in real time would further
validate the clinical effectiveness and usefulness of ML models.
While clinical outcomes are important to establish (e.g. survival,
length of stay in hospital, duration of antimicrobial therapy, rate of
complications, readmission rate), insights into how clinicians will
integrate ML in clinical practice are also highly needed. No ran-
domized controlled trial could be identified in our review.
Model interpretability
With three exemptions, studies in our review did not explicitly
highlight ML model explainability or interpretability in their ob-
jectives. However, efforts are also being made in other fields to
increase the interpretability of ML models (Fig. 3) [79,80].
It is of great importance to further explore perceptions, inter-
pretation, and trust in ML decision support with the potential users
(i.e. physicians, other healthcare providers, and patients) and how
to avoid the black box notion of ML applications. This could
improve the ‘algorithm literacy’ of clinicians and help them to
understand when to trust a model and when and why errors might
occur [81]. In our review one study in the sepsis group that used
reinforcement learning applied a random forest model to explain
the developed model and reported these findings in their supple-
mentary materials [19]. Two studies provided a web interface to
study variable importance in the developed ML models [11,35].
However, just recently a debate has unfolded as to whether inter-
pretable predictive models, such as logistic regression, should be
preferred over explainable models (demonstrated in Fig. 3) when
profound background knowledge is available (e.g. established risk
factors for a specific disease) [82]. The author argues that using an
explanatory model on top of a black box model cannot be as correct
as the original model, otherwise the model could be used in the
first place. Such an approach could lead to the risk that any
explanatory method for a black box model could be an inaccurate
representation of the original model [82]. The use of ML models
should thus be based on thorough reasoning and not only on the
availability of new and sophisticated technology.
Limitations
For this review, only the MEDLINE database was queried for
relevant articles. The search term for infections might not detect all
relevant articles. Systematically focusing on specific topics, such as
sepsis, extended to additional databases (e.g. EMBASE, Google
Scholar) will most likely capture additional studies that were not
included in the umbrella term of infection. Nevertheless, it hasthat led to the prediction. Adapted from [80] with the authors' permission.
gement using routine electronic health records: tools, techniques, and
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Table 3
Core issues and recommendations for the development of machine learning models for infection management based on this narrative review
Core issue Recommendation
Data and modelling Clear definition of the predicted outcome
Inclusion and evaluation of model interpretability and explainability with the end-user in mind (e.g. nurses, physicians)
Reporting Adhering to reporting guidelines (e.g. RECORD, TRIPOD)
Making software code openly available
Using open-source programming languages
Study design Model validation with external data (multicentre studies)
Clinical evaluation of machine learning models
Evaluation of the adoption and integration of machine learning models into clinical workflows by end-users
C.F. Luz et al. / Clinical Microbiology and Infection xxx (xxxx) xxx 7already become apparent that the large heterogeneity within the
body of literature hindered a more detailed comparison of the
included studies. Viral infections were not part of this review. The
complementary work by Peiffer-Smadja et al. identified ten studies
which, however, did not meet our inclusion criteria for study year,
patient population, study data, or MEDLINE index [9]. They iden-
tified a special focus on ML and HIV infections. A systematic survey
on this topic can provide further information [83]. Our review used
a grouping approach to stratify the included studies. These groups
of research areas are limited as SSI could also be grouped under
HAI. However, for this review we decided to keep surgery-related
infection separate from other infections based on our search
results.Conclusion
The use of AI/ML in the field of infection management is still in
its infancy [84]. Our review revealed several promising approaches
such as the use of LSTM for early sepsis detection. Three identified
studies validated their results using external data. However, no
clinical trial or clinical assessment of an ML model could be iden-
tified. The clinical utility of AI/ML, preferably in randomized
controlled trials, has still to be demonstrated (Table 3). Moreover, in
the future it will be crucial to explore the best ways to integrate AI/
ML into clinical workflows as this was not yet part of the identified
studies in this review. The global challenges of AI/ML in infectious
diseases have also been recently described in a complementary
review [9]. In addition, we have detected and highlighted the ne-
cessity for improved reporting, a stronger focus on explainability
and interpretability, and clinical validation of developed ap-
proaches to secure the next steps towards a happy ‘childhood’ and a
positive clinical impact.Author contributions
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